NSC
57
7
NRG
52
3
AVGO
22
2
DHI
44
-4
KMI
69
2
DE
56
10
JPM
67
4
CINF
51
4
ICE
62
3
GWW
71
4
WEC
55
2
PLD
48
-5
BK
72
4
ABT
62
5
ISRG
76
2
MRO
40
-15
PM
64
2
AXP
69
3
C
60
2
APH
67
3
NSC
57
7
NRG
52
3
AVGO
22
2
DHI
44
-4
KMI
69
2
DE
56
10
JPM
67
4
CINF
51
4
ICE
62
3
GWW
71
4
WEC
55
2
PLD
48
-5
BK
72
4
ABT
62
5
ISRG
76
2
MRO
40
-15
PM
64
2
AXP
69
3
C
60
2
APH
67
3
Financhill
Back

Karyopharm Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
28

KPTI
Karyopharm Therapeutics

Last Price:
0.85
Seasonality Move:
-2.8%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%
Sell
28
Karyopharm Therapeutics (KPTI) is a Sell

Is Karyopharm Therapeutics a Buy, Sell or Hold?

  • The current Karyopharm Therapeutics [KPTI] share price is $0.78. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • KPTI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.75. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KPTI Stock Price Chart

What is Karyopharm Therapeutics's stock price today?

  • The Karyopharm Therapeutics share price today is $0.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.

KPTI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.33 Sell
Chaikin Money Flow: -20521 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.81 - 0.91) Sell
Bollinger Bands (100): (0.76 - 0.92) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 47.09 Sell
Chaikin Money Flow: 727660 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.94 - 28.86) Sell
Bollinger Bands (100): (28.59 - 38.65) Sell

KPTI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.82 Sell
20-day SMA: 0.86 Sell
50-day SMA: 0.82 Sell
200-day SMA: 1.02 Sell
8-day EMA: 0.81 Sell
20-day EMA: 0.84 Sell
50-day EMA: 0.84 Sell
200-day EMA: 1.01 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.78 Sell
20-day SMA: 28.02 Sell
50-day SMA: 29.23 Sell
200-day SMA: 42.54 Sell
8-day EMA: 27.83 Sell
20-day EMA: 28.09 Sell
50-day EMA: 29.85 Sell
200-day EMA: 39.55 Sell

Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.

Karyopharm Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):